Page not found
HOME / Page not found

Conference Speakers

Cultural Speakers

Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.

At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:

- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Dr. Second Speaker Name
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
- -
Dr. Speakers Name Max Length
Speaker Credentials
View Registration Info
Speakers

Speakers (522)

Saturday, 23 November 2024 06:40

Pradeep Chauhan

Written by
Saturday, 23 November 2024 06:40

Aadel Chaudhuri

Written by
Saturday, 23 November 2024 06:40

Silvia Calabuig Fariñas

Written by
Saturday, 23 November 2024 06:40

Julia Burnier

Written by
Saturday, 23 November 2024 06:40

Leslie Bucheit

Written by
Saturday, 23 November 2024 06:40

Jacob Berchuck

Written by
Saturday, 23 November 2024 06:40

Valsamo Anagonostou

Written by
Saturday, 23 November 2024 06:40

Hashem Alshurafa

Written by
Friday, 27 September 2024 03:39

Roberta Carbone

Written by
Dr. Carbone, the Chief Scientific Officer (CSO) of Tethis, holds a Ph.D. in Forensic Medicine and recently completed a Master's Degree in Technology and Innovation. With an extensive background in life sciences, research and development, she has a passion for driving innovation in the field. Dr. Carbone has gained significant experience during her tenure at prestigious institutions, including several years at the National Institute of Health in Bethesda, USA, and a decade at the European Institute of Oncology in Milan, Italy. Her research has primarily focused on technological development and innovation in oncology.
At Tethis, one of her most notable achievements was the successful market introduction of a groundbreaking diagnostic device for analyzing genetic diseases by FISH. Currently, she is spearheading the development of the diagnostic workflow for the liquid biopsy project, a cutting-edge initiative aimed at revolutionizing cancer diagnostics.
Dr. Carbone has co-authored more than 30 peer-reviewed publications and is the lead inventor on several patents, underscoring her contributions to the advancement of medical technology and her commitment to improving patient outcomes.
Friday, 27 September 2024 03:33

Ryan Demers

Written by
As the Global Director for Lung Diagnostics and Liquid Biopsy Strategy, Ryan supports both the lung cancer biomarker strategy for the current and future AstraZeneca therapeutic portfolio, as well as the broader Global Commercial Diagnostics strategy for liquid biopsy, across tumor types. Ryan has over 15 years’ experience in the molecular diagnostics space and has held a variety of roles in the areas of research and development, commercial leadership and strategy and partnerships. Ryan holds a Masters of Science in Molecular Biophysics degree from the University of Guelph.
Page 11 of 38